ArticleNeuro-oncology advances

Boron neutron capture therapy plus bevacizumab versus bevacizumab alone in recurrent glioblastoma: A propensity score-matched analysis.

Shuo-Fu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.